WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2006

Mar 2, 2006

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2006-02-28

Reporting Person: MOREL DONALD E JR (Chair of the Board & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2006-02-28	Common Stock	M	30191	$13.3750	Acquired	271109.6110	Direct
2006-02-28	Common Stock	F	12471	$32.3800	Disposed	258638.6110	Direct
2006-02-28	Common Stock	F	7196	$32.3800	Disposed	251442.6110	Direct
2006-02-28	Common Stock	M	2675	$14.7032	Acquired	254117.6110	Direct
2006-02-28	Common Stock	F	1215	$32.3800	Disposed	252902.6110	Direct
2006-02-28	Common Stock	F	593	$14.7032	Disposed	252309.6110	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2006-02-28	Stock Option (Right to Buy)	$13.3750	M	30191	Disposed	2006-05-01	Common Stock (30191.00)	Direct
2006-02-28	Stock Option (Right to Buy)	$14.7032	M	2675	Disposed	2007-08-05	Common Stock (2675.00)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	771.1149	Indirect
Common Stock	12663.2889	Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.